NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st

4 January 2020 - Companies can now submit medicines for the new Innovative Licensing and Access Pathway following close collaboration between ...

Read more →

Jacinda Ardern defends Labour's 'perfectly reasonable' decision to veto MP led PHARMAC inquiry

7 December 2020 - Prime Minister Jacinda Ardern is defending Labour's "perfectly reasonable" decision to veto a PHARMAC inquiry led ...

Read more →

Stage 2 PBS process improvements – consultation closed

13 October 2020 - On 21 September 2020, the department hosted a webinar to provide information to industry on the ...

Read more →

NICE proposes simplifying how medicines and medical devices are selected for evaluation

12 October 2020 - As part of the work underway to review the methods and processes NICE uses to develop guidance ...

Read more →

Implementation of Stage 2 PBS process improvements from 1 January 2021

7 October 2020 - As announced by Government in the 2020-21 Budget, Stage 2 PBS process improvements will commence from ...

Read more →

PHARMAC confirms their new way of contracting for medicines

7 October 2020 - PHARMAC is standardising the way medicines are contracted, providing better support to health care professionals when ...

Read more →

Proposal to decline inactive funding applications

1 October 2020 - To help make the decision-making process clearer, PHARMAC is seeking feedback on a proposal for the ...

Read more →

Updated financial estimates workbook

30 September 2020 - An updated version of the Utilisation and Cost Model workbook and User Manual are now available to ...

Read more →

Stage 2 PBS process improvement information forum – webinar recording and resources available

24 September 2020 - On 21 September 2020, the department hosted a webinar to provide information to industry on the Stage ...

Read more →

PBS process improvements – Stage 2 Fact Sheet

21 September 2020 - Pending Government decision, the implementation of Stage 2 PBS process improvements are expected to commence from ...

Read more →

After 20 years of using economic evaluation, should NICE be considered a methods innovator?

13 January 2020 - NICE is only one of several organisations internationally that uses economic evaluation as part of decision ...

Read more →

Information on efficient funding of chemotherapy reviewed

5 December 2019 - The publicly available information for the Efficient Funding of Chemotherapy has been revised and is now available. ...

Read more →

PHARMAC announces faster assessment of cancer medicines

4 December 2019 - From 1 January 2020, PHARMAC will assess funding applications for new cancer medicines at the same ...

Read more →

Plans for measles vaccinations to be distributed back through PHARMAC

26 November 2019 - Measles vaccinations in the south will likely go back to being distributed by PHARMAC after being ...

Read more →

Revised process for cell and gene therapies

21 November 2019 - CADTH has undertaken an internal review and established a novel process for the review of cell and ...

Read more →